Cite
HARVARD Citation
Ruggiero, A. et al. (2022). Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice. Clinical and experimental dermatology. pp. 561-567. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ruggiero, A. et al. (2022). Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice. Clinical and experimental dermatology. pp. 561-567. [Online].